Loading page…

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	25	21	29	12	0	0	0	0	0	1
	25	21	28	12	0	0	0	0	0	1
	1	0	0	0	-0	0	-0	-0	-0	0
OPM %	2%	2.3%	1.5%	2.8%	—	—	—	—	—	19.9%
Depreciation	0	0	—	—	0	0	0	0	0	0
Interest	—	0	0	0	0	0	0	0	0	0
	—	—	—	—	0	0	0	0	0	0
Profit before tax	0	0	0	0	-0	0	-0	-0	0	0
Tax	0	0	0	—	0	0	0	0	0	0
Tax %	41.7%	75%	0%	—	0%	—	0%	0%	0%	23.5%
	-13	0	0	-0	-0	0	-0	-0	0	0
PAT margin %	-49.3%	0.1%	0.1%	-0.2%	—	—	—	—	—	19.1%
EPS (₹)	-11.8	0	—	—	-0.2	0	-3.7	-3.3	4.3	0.7
EPS adjusted (₹)	—	—	—	—	-0.2	0	-3.7	-3.3	4.4	0.3
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	11	0	0	0	0	8
Reserves	-11	-0	-0	-1	-0	-0
Minority interest	—	0	—	—	—	—
	2	0	0	0	2	0
	3	0	0	0	0	2
Total equity & liabilities	5	0	0	0	2	11
	0	0	0	0	0	0
CWIP	0	0	0	—	—	0
Investments	0	0	0	0	0	0
	4	—	0	0	2	11
Total assets	5	0	0	0	2	11

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	4	12	-0	-0	-1	-5
	4	0	0	0	0	0
	5	-12	0	0	1	8
Net cash flow	13	0	0	-0	0	3
Free cash flow	4	12	-0	-0	-1	-5
CFO / Operating profit %	—	—	—	—	—	—

iSERA Lifesciences Ltd

Profit & loss